Rethinking Diabetes Treatment: Cortisol, GLP-1 Agonists, and Prediabetes

The Role of Cortisol in Diabetes

• 💡 Hypercortisolism is a significant factor in difficult-to-control type 2 diabetes, affecting nearly 25% of patients.
• 🔬 The CATALYST study explored mifepristone, a cortisol receptor antagonist, showing a 1.5% reduction in HbA1c and significant weight loss.
• ⚠️ While effective, mifepristone has side effects like nausea, fatigue, and headaches, with nearly half of participants discontinuing use.
• 🩺 Physicians are urged to consider checking cortisol levels in patients struggling with diabetes management.

Advances in Diabetes Medication

• 🚀 GLP-1 receptor agonists like Ozempic and Mounjaro have revolutionized diabetes treatment, aiding blood sugar control and weight loss.
• 🧪 The origin of these drugs traces back to a peptide found in Gila monster saliva, leading to the development of exenatide.
• 💊 A new oral formulation of semaglutide shows promise for weight loss, offering an alternative to injections for those who prefer pills.
• 📈 SGLT2 inhibitors (e.g., Jardiance) are also highlighted for their benefits in reducing glucose excretion, aiding weight loss, and improving kidney and heart outcomes.

Understanding and Managing Prediabetes

• ⚠️ Prediabetes indicates an increased risk of developing diabetes but is not a guarantee, with interventions significantly reducing this risk.
• 🏃 Lifestyle interventions, including 150 minutes of moderate-to-vigorous physical activity per week and calorie restriction leading to 5-10% weight loss, can reduce diabetes risk by about 50%.
• 💊 Metformin has shown effectiveness in reducing prediabetes risk, particularly in younger individuals, those with higher glucose levels, and women with prior gestational diabetes.
• 📊 Continuous Glucose Monitors (CGMs) offer insights into individual blood sugar responses to food, but caution is advised against over-reliance on technology without understanding the broader health implications.

Future Directions in Diabetes Research

• 🌱 Research into type 1 diabetes is exploring adjunctive therapies, including GLP-1 receptor agonists and novel immune-modifying strategies.
• 🧬 Exciting advancements include stem cell-derived therapies and gene-modifying techniques to create insulin-producing beta cells without the need for immunosuppression.
• 🍽️ Key dietary recommendations for the future include reducing processed foods and emphasizing a wide variety of whole foods.
• ⚖️ Exercise is crucial for weight loss to preserve muscle mass and maintain energy levels.